Related Experiment Video
Updated: May 5, 2026
08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
27.0K
All roads lead to cholesterol: Modulating lipid biosynthesis in multiple sclerosis patient-derived models
Sophie Eichhorner1, Larissa Traxler1, Oliver Borgogno1
1Department of Neurosciences, Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, USA; Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, USA.
Cell Stem Cell
|November 8, 2024
Summary
Cholesterol metabolism impacts multiple sclerosis (MS) cell dysfunction. Inhibiting cholesterol production improved key cell issues, suggesting this pathway is a promising therapeutic target for MS treatment.
Area of Science:
- Neuroscience
- Cell Biology
- Metabolic Research
Background:
- Multiple sclerosis (MS) involves inflammatory and dysfunctional cellular phenotypes.
- Cholesterol metabolism has been implicated in the pathogenesis of MS.
- Previous studies highlight the need for further investigation into cellular mechanisms in MS.
Purpose of the Study:
- To investigate the role of cholesterol metabolism in MS-driven cellular phenotypes.
- To evaluate the therapeutic potential of targeting cholesterol biosynthesis in MS models.
Main Methods:
- Utilized patient-derived cell models from individuals with multiple sclerosis.
- Examined cellular phenotypes related to inflammation and dysfunction.
- Assessed the effects of inhibiting cholesterol biosynthesis on these cellular phenotypes.
Main Results:
- Studies confirmed a significant role for cholesterol metabolism in MS cellular phenotypes.
- Inhibition of cholesterol biosynthesis led to the amelioration of critical cellular dysfunctions.
- These findings underscore the link between cholesterol pathways and MS pathology.
Conclusions:
- Cholesterol metabolism is a key factor in the inflammatory and dysfunctional cellular phenotypes observed in multiple sclerosis.
- Targeting cholesterol biosynthesis presents a potential therapeutic strategy for managing MS.
- Further research into this metabolic pathway is warranted for MS treatment development.
Related Concept Videos
01:31Lipid-derived Compounds in the Human Body
5.5K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
01:29Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
01:30Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
01:19Multiple Sclerosis l: Introduction
31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31